We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$322M
AUM Growth
+$9.28M
Cap. Flow
+$1.33M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.21M
2
ACN icon
Accenture
ACN
+$5.86M
3
LH icon
Labcorp
LH
+$5.52M
4
EA icon
Electronic Arts
EA
+$5.12M
5
LRCX icon
Lam Research
LRCX
+$4.42M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.03M
2
KR icon
Kroger
KR
+$5M
3
MHK icon
Mohawk Industries
MHK
+$4.88M
4
SLB icon
SLB Ltd
SLB
+$3.51M
5
MPC icon
Marathon Petroleum
MPC
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.09%
2 Technology 14.53%
3 Industrials 11.48%
4 Communication Services 9.95%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$4.43T
$4.59M 1.43%
114,260
-300
-0.3% -$11.7K
PFE icon
27
Pfizer
PFE
$147B
$4.55M 1.41%
141,454
-23
-0% -$769
DAL icon
28
Delta Air Lines
DAL
$61.3B
$4.47M 1.39%
113,535
-625
-0.5% -$23.6K
BMY icon
29
Bristol-Myers Squibb
BMY
$130B
$3.95M 1.22%
73,221
+1,405
+2% +$90.3K
PEP icon
30
PepsiCo
PEP
$189B
$3.87M 1.2%
35,573
-225
-0.6% -$24.2K
ED icon
31
Consolidated Edison
ED
$39.9B
$3.55M 1.1%
47,153
-2,685
-5% -$209K
AGN
32
DELISTED
Allergan plc
AGN
$3.31M 1.03%
14,349
-715
-5% -$175K
NSC icon
33
Norfolk Southern
NSC
$76.8B
$3.02M 0.94%
31,097
-410
-1% -$37.3K
D icon
34
Dominion Energy
D
$60B
$2.96M 0.92%
39,888
-1,908
-5% -$145K
T icon
35
AT&T
T
$158B
$2.94M 0.91%
95,801
-132
-0.1% -$4.17K
SO icon
36
Southern Company
SO
$107B
$2.9M 0.9%
56,538
-2,890
-5% -$152K
VZ icon
37
Verizon
VZ
$193B
$2.79M 0.87%
53,753
-1,194
-2% -$64.1K
INTC icon
38
Intel
INTC
$510B
$2.56M 0.79%
67,752
+2,975
+5% +$105K
DOC icon
39
Healthpeak Properties
DOC
$15B
$2.49M 0.77%
72,057
-3,322
-4% -$116K
LLY icon
40
Eli Lilly
LLY
$1.04T
$2.44M 0.76%
30,435
-1,775
-6% -$142K
TFC icon
41
Truist Financial
TFC
$64.6B
$2.44M 0.76%
64,769
-2,667
-4% -$99.3K
VNQ icon
42
Vanguard Real Estate ETF
VNQ
$39.2B
$2.42M 0.75%
27,853
+175
+0.6% +$15.6K
VWO icon
43
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$2.38M 0.74%
63,381
+8,630
+16% +$321K
JPC icon
44
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$2.35M 0.73%
234,150
+8,900
+4% +$91.6K
TRV icon
45
Travelers Companies
TRV
$79.8B
$2.18M 0.68%
19,041
+7,015
+58% +$821K
EFX icon
46
Equifax
EFX
$20.8B
$2.06M 0.64%
15,335
– –
PGEN icon
47
Precigen
PGEN
$2.47B
$2.01M 0.62%
72,257
+8,357
+13% +$221K
NUV icon
48
Nuveen Municipal Value Fund
NUV
$1.9B
$1.97M 0.61%
185,875
-500
-0.3% -$5.33K
CSCO icon
49
Cisco
CSCO
$479B
$1.96M 0.61%
61,805
+1,760
+3% +$54.1K
UTF icon
50
Cohen & Steers Infrastructure Fund
UTF
$3.05B
$1.94M 0.6%
90,238
+3,500
+4% +$74.9K
1
2
3 4 5

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review

As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
  • Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
  • Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
  • Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.